Sleep and Fatigue

Vascarta Inc. is a pharmaceutical company that has developed a patented topical/transdermal delivery platform aimed at improving the bioavailability of drugs, particularly curcumin, a compound known for its anti-inflammatory and antioxidant properties. The company focuses on addressing unmet medical needs through innovative formulations that enhance therapeutic efficacy and patient outcomes.

Founded in 1960 by Dr. Joseph V. Brady, the Institutes for Behavior Resources, Inc. (IBR) is a nonprofit organization dedicated to enhancing the growth of behavioral sciences and their application to human affairs through research, clinical services, and educational initiatives. IBR focuses on addressing social challenges through innovative research and comprehensive health services.

NeuroGeneces is dedicated to improving neurological health and cognitive longevity through innovative sleep science. Their proprietary NeuroInsight assessment detects atypical brain decline years before symptoms emerge, allowing for timely interventions. The company also offers NeuroGevity, a system that enhances slow-wave sleep to improve memory and cognitive function. With a focus on early detection and intervention, NeuroGeneces aims to change the trajectory of neurodegeneration and promote better brain health.

Massachusetts General Hospital (Mass General) is a world-renowned academic medical center and the original and largest teaching hospital of Harvard Medical School. Mass General is recognized for its commitment to high-quality patient care, innovative research, and comprehensive educational opportunities. The hospital operates the largest hospital-based research program in the United States, fostering collaboration among leading clinicians and scientists to bridge innovation science with state-of-the-art clinical medicine. Mass General for Children (MGfC) is a leader in pediatric care, offering more than 50 medical specialties and 15 surgical services, and is home to the only proton beam facility in New England. The hospital is dedicated to serving local and global communities, training the next generation of healthcare professionals, and advancing medical knowledge through groundbreaking research, multidisciplinary care, and a strong commitment to family-centered and equitable healthcare.

CRI Genetics, part of the Cellular Research Institute, aims to unlock complex genetic information and present it in an engaging and useful manner. Their mission is to enhance human life and advance the understanding of the human genome through consumer genetic reports and active participation in scientific research. They believe genetic analysis is the future of medicine and are committed to solving complex medical problems. The company ensures the privacy and security of customer data, offering an 8-week efficiency guarantee for delivering genetic reports.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

Ultimaxx Health is a pioneering company dedicated to developing innovative plant-based medicines and natural solutions to address pressing public health issues, chronic conditions, and general health and wellness. With a mission to change the world naturally, Ultimaxx Health focuses on creating non-narcotic, non-habit forming alternatives to prescription painkillers, aiming to improve the general health and well-being of humanity. The company leverages advanced science and technology, including digital health technologies, AI, and data analytics, to promote healthy aging and optimize consumer health through personalized, data-driven approaches.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

EuMentis Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies for serious neuropsychiatric conditions. The company integrates clinically validated science with cutting-edge technology to create effective treatments for conditions like Tourette syndrome and autism spectrum disorder, focusing on restoring balance in neurotransmitter systems.

The Ohio State University is a leading public research institution dedicated to advancing knowledge, solving societal challenges, and driving prosperity through innovative research and education. With a strong commitment to research integrity and compliance, the university supports faculty and staff in all stages of sponsored projects, from identifying funding sources to award management.

Evren Technologies is a bioelectronic medical device company focused on transforming the treatment of Post Traumatic Stress Disorder (PTSD) through non-invasive Vagal Nerve Stimulation (VNS) technologies. Their mission is to empower patients to rise above PTSD and improve their lives with innovative solutions.

Senseye is pioneering a breakthrough diagnostic platform for mental health, focusing initially on PTSD. The company aims to empower clinicians with fast, accurate tools to personalize care by establishing clear baselines and tracking outcomes over time. Senseye's innovative approach leverages brain-based diagnostics and computer vision technology to transform the diagnostic process for PTSD, anxiety, depression, and addiction into an objective process. Their platform operates on everyday smartphones, making it accessible and efficient, without the need for specialized equipment.

Snoretox Ltd. is an innovative biotech company focused on developing a drug to treat Brachycephalic Obstructive Airways Syndrome (BOAS) and various human muscle weakness conditions. Based in Melbourne, Australia, the company has patented a novel therapeutic that utilizes modified tetanus toxin to enhance muscle tone, similar to how Botox works with botulinum toxin. Their mission is to improve the quality of life for individuals suffering from muscle-related disorders through groundbreaking biotherapeutics.

Phelix Medical is a precision health company dedicated to advancing pharmacogenomics (PGx) as a tool for health equity, safer prescribing, and personalized care. We specialize in delivering inclusive PGx testing, real-time clinical decision support, and secure data integration for providers, payers, and patients—particularly in underserved and high-risk populations. Through strategic partnerships with CLIA-certified labs, EHR integrators, and public health educators, Phelix Medical supports scalable PGx programs across federal systems, community clinics, and telehealth networks. Whether improving medication safety for military health readiness or enabling precision prescribing in minority communities, our solutions are built to inform, empower, and deliver outcomes where they matter most.